ClearPoint Neuro, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2018

Stock option activity under all of the Company’s Plans during the nine months ended September 30, 2018 is summarized below:

	Shares			Weighted - Average Exercise Price
Outstanding at December 31, 2017		1,238,199		$	12.47
Granted		147,500			1.81
Forfeited		(13,162	)		15.02
Outstanding at September 30, 2018		1,372,537		$	11.30

Schedule of share-based compensation expense

The Company records share-based compensation expense on a straight-line basis over the related vesting period. For the three and nine months ended September 30, 2018 and 2017, share-based compensation expense related to options was:

Three Months Ended September 30,
2018		2017
$	208,207	$	186,982

Nine Months Ended September 30,
2018		2017
$	968,488	$	616,007

Schedule of common stock warrant activity

Warrants have generally been issued for terms of up to five years. Common stock warrant activity for the nine months ended September 30, 2018 was as follows:

	Shares			Weighted - Average Exercise Price
Outstanding at December 31, 2017	8,949,078		$	4.12
Issued	-			-
Exercised	(221,773	)		2.20
Expired / Terminated	(49,749	)		2.00
Outstanding at September 30, 2018	8,677,556		$	4.18

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details